A detailed history of Accent Capital Management, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Accent Capital Management, LLC holds 2,986 shares of LLY stock, worth $2.41 Million. This represents 1.66% of its overall portfolio holdings.

Number of Shares
2,986
Previous 2,974 0.4%
Holding current value
$2.41 Million
Previous $2.31 Billion 16.85%
% of portfolio
1.66%
Previous 2.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$724.87 - $909.04 $8,698 - $10,908
12 Added 0.4%
2,986 $2.7 Billion
Q1 2024

May 13, 2024

BUY
$592.2 - $792.28 $101,266 - $135,479
171 Added 6.1%
2,974 $2.31 Billion
Q4 2023

Mar 19, 2024

BUY
$525.19 - $619.13 $1.47 Million - $1.74 Million
2,803 New
2,803 $1.63 Billion

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $766B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Accent Capital Management, LLC Portfolio

Follow Accent Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Accent Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Accent Capital Management, LLC with notifications on news.